Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Murdo Gordon
Pharma
Amgen doesn't think Repatha's sales wins will stop anytime soon
With Repatha and several other key growth drivers, Amgen has outpaced declines from biosimilar competition to key brands in Q2.
Fraiser Kansteiner
Aug 4, 2026 4:01pm
Amgen reaps Horizon buyout rewards in Q3, preps biosim launches
Oct 31, 2024 7:50am
In quarterly earnings report, Amgen shows off Lumakras launch
Nov 3, 2021 11:50am
Amgen scores Otezla patent win, nabbing protection until 2028
Sep 21, 2021 10:00am
Early days, but Lumakras expectations are high, Amgen execs say
Aug 5, 2021 9:50am
Amgen contends IRS' bid for $3.6B in back taxes
Aug 4, 2021 8:25am
